Abstract:Background Low muscle strength and mass with possible impaired physical performance characterizes the muscle disease known as sarcopenia. When not diagnosed or treated, the risk of falls, fractures, hospitalization, hospital costs, longer hospital stays, and negative outcomes increases. In the presence of comorbidities, such as cardiovascular diseases, sarcopenia can be significant and serious. In these patients, muscle weakness has attracted considerable attention in recent years since it is deemed an independent risk factor for disability and a strong predictor of premature death. The SARC-F (simple questionnaire to rapidly diagnose sarcopenia), a valid and consistent instrument to detect people at risk of adverse outcomes associated with sarcopenia, including functional decline, can be used as a screening tool. It consists of 5 items self-reported by patients based on their perceptions regarding strength limitations, the ability to walk, rise from a chair, climb stairs and a number of falls. Objectives Analyze the risk of sarcopenia and identify associated factors in hospitalized older adults with cardiovascular disease. Methods This is a cross-sectional study conducted with 23 hospitalized older adults with cardiovascular disease in a tertiary hospital of the Federal District, Brazil, classified into two groups: with or without risk of sarcopenia according to the SARC-F. Demographic (age and sex), clinical (number of medications and body mass index –BMI) and physical data (muscle strength and mass) were collected. Muscle strength was assessed using handgrip dynamometry and the Medical Research Council (MRC) scale, and mass by means of electrical bioimpedance. These data were compared between the groups using the student´s t and Mann-Whitney U tests. Results There was a risk of sarcopenia in 39.1% (n=9) of the sample. In comparison analyses, the group of older adults at risk of sarcopenia were older (mean difference: 14.39 years [95%CI 8.23 – 20.55]; p=0.001), exhibited lower handgrip strength (mean difference: 9.36 KgF [95%CI 0.874 – 17.854]; p=0.032), more frequent muscle weakness on the MRC scale (X²(1)=5.367, p=0.047) and lower appendicular muscle mass (mean difference: 0.763 [95%CI 0.113 – 1.414]; p=0.024). The groups showed no differences for sex, BMI and number of continuous use drugs (p>0.05). Conclusion This study found that older adults at risk of sarcopenia are older and obtain worse physical results when compared to their risk-free counterparts. The SARC-F was able to identify hospitalized patients with lower strength and muscle mass. Implications The findings show the need to identify hospitalized older adults at risk of sarcopenia using a simple, fast, low-cost, noninvasive assessment, which may contribute to the establishment of early identification strategies in a hospital setting, aimed at developing more assertive measures.

Risk of sarcopenia in hospitalized patients and related clinical factors: a multicenter study from Turkey

Incidence and risk factors of sarcopenia in hospitalized survivors of COVID-19; a retrospective cohort study

Effects of sarcopenia on changes in prevalence of patients with depressive mood during hospitalization in geriatric rehabilitation

Prevalence of sarcopenia and related factors in community-dwelling elderly individuals

RISK OF SARCOPENIA AND ASSOCIATED FACTORS IN HOSPITALIZED OLDER ADULTS WITH CARDIOVASCULAR DISEASE

Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease

The incidence of sarcopenia among hospitalized older patients: results from the Glisten study

SARCOPENIA IN ELDERLY PATIENTS: WHAT ARE THE CONTRIBUTING RISK FACTORS?

Sarcopenia and Associated Factors in Adults Aged 40 and Above: A Study Conducted in Primary Healthcare

Relationship Between Dysphagia and Sarcopenia with Comprehensive Geriatric Evaluation

Sarcopenia, frailty prevalence, and related factors in patients with stroke: A cross-sectional analytical study from Turkey

Prevalence and Prognostic Implications of Sarcopenia in Older Patients with Coronary Heart Disease.

Factors affecting sarcopenia in older patients with chronic diseases

Prevalence and predictive value of sarcopenia in hospitalized patients with ischemic colitis

Evaluation of Probable Sarcopenia’s Prevalence in Hospitalized Geriatric Patients Using Ishii’s Score

Prevalence and factors associated with sarcopenia among older adults in a post-acute hospital in Singapore

A 6-Month Follow-Up Study

Impact of sarcopenia on 1-year mortality in older patients with cancer

PREVALENCE OF SARCOPENIA IN OSTEOPOROSIS PATIENTS

Correlational analysis of sarcopenia and multimorbidity among older inpatients

Sarcopenia in older patients with idiopathic normal pressure hydrocephalus: an observational study from a single geriatric clinic in Turkey